Farallon Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-725,000
| Closed | -$80.7M | – | 147 |
|
|
2020
Q3 | $80.7M | Buy |
+725,000
| New | +$80.7M | 0.56% | 49 |
|
|
2019
Q3 | – | Sell |
-1,200,000
| Closed | -$75.9M | – | 107 |
|
|
2019
Q2 | $75.9M | Buy |
1,200,000
+150,000
| +14% | +$9.48M | 0.49% | 47 |
|
|
2019
Q1 | $50.6M | Sell |
1,050,000
-200,000
| -16% | -$9.63M | 0.38% | 49 |
|
|
2018
Q4 | $41.9M | Sell |
1,250,000
-100,000
| -7% | -$3.35M | 0.31% | 46 |
|
|
2018
Q3 | $70.7M | Sell |
1,350,000
-240,000
| -15% | -$12.6M | 0.42% | 42 |
|
|
2018
Q2 | $49.8M | Sell |
1,590,000
-260,000
| -14% | -$8.14M | 0.31% | 51 |
|
|
2018
Q1 | $40.3M | Buy |
1,850,000
+685,000
| +59% | +$14.9M | 0.28% | 53 |
|
|
2017
Q4 | $23.5M | Buy |
+1,165,000
| New | +$23.5M | 0.19% | 51 |
|